baber/WOPTO huggingface dataset:
Patent CA-2672121-A1 (CA)
Inventor: PHILLIPS JOE D
IPC: C08G18/36
Filed: 2007-12-03
Abstract: An aldehyde composition containing a mixture of mono-formyl-, diformyl-, and triformyl-substituted fatty acids and/or fatty acid esters having a di-aldehyde/tri-aldehyde weight ratio of less than 5/1 and an average functionality number from greater than 0.96 to less than 1.26. A monomer alcohol composition containing a mixture of mono-hydroxymethyl-, dihydroxymethyl-, and trihydroxymethyl-substituted fatty acids and/or fatty acid esters having a diol/triol weight ratio of less than 5/1 and an average functionality number from greater than 0.90 to less than 1.20. The monomer alcohol can be converted into an oligomeric polyol for use in the manufacture of polyurethane flexible foams.
Patent CA-2674192-A1 (CA)
Inventor: BOCCACCI ROBERTO
IPC: G06K9/00
Filed: 2007-12-31
Abstract: Device (1) for the taking of fingerprints, wherein the fingerprint is impressed on an impression surface (3) of a prism (5), allows to obtain of a predetermined image by indirect light, less sensitive to the presence of residues and dirt, and comprises a light source (15) laterally placed with respect to the taking surface (11) on which the fingerprint is impressed, one surface (12) adjacent to that on which the fingerprint is impressed being treated so as to have one layer (13) having a reduced reflectivity directed toward the inside of the prism (5).
Patent CA-2676133-A1 (CA)
Title: Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage
Inventor: LEMMONDS CHARLOTTE A
IPC: A61K31/13
Filed: 2007-10-08
Abstract: Compositions useful for treating an individual with nicotine dependence comprising a combination of an .alpha.3.beta.4 nicotinic receptor antagonist and a nicotine metabolite are disclosed. More particularly, compositions comprising dextromethorphan, dextrorphan or a pharmaceutically acceptable salt thereof and further comprising cotinine or a pharmaceutically acceptable salt thereof are disclosed. Methods of alleviating nicotine withdrawal symptoms and/or tobacco usage by administration of these compositions are also disclosed.
Patent CA-2679312-A1 (CA)
Title: Co-crystals and pharmaceutical compositions comprising the same
Inventor: KADIYALA IRINA
IPC: A61K31/497
Filed: 2008-02-27
Abstract: The invention relates to compositions and co-crystals each comprising VX-950 and a co-crystal former selected from the group consisting of 4-hydroxybenzoic acid, 4-amino salicylic acid, phenylalanine, threonline, tartaric acid, adipic acid, succinic acetate, proline, methyl 4-hydroxybenzoate, anthranilic acid, and d-Biotin. Also within the scope of this invention are methods of making and using the same.
Patent CA-2682379-A1 (CA)
Inventor: KITANO JUNICHI
IPC: F16K7/02
Filed: 2008-04-04
Abstract: A device for stopping a flow of fluid in a fixed length of tube with an actuator simple in construction is provided. The stopping device is free of direct touch with the fluid inside the tube, expected not to obstruct the flow in the tube as permitted as possible at normal condition, expected to perform both detection and control with a single device, and further invulnerable to kinds of fluids. The device for stopping a flow of fluid includes a tube holder to keep a tube in looped configuration, a movable part pressing the looped configuration of the tube. Pressing of the looped configuration of the tube make a snapped bent to stop the flow of fluid passed through the tube. Putting the movable part back into place results in the tube's returning from the configuration having the bent, allowing the fluid flowing again through the tube.
Patent CA-2682885-A1 (CA)
Title: Waste stabilization and packaging system for fissile isotope-laden wastes
Inventor: HODGES STANLEY M JR
IPC: G21F5/00
Filed: 2008-03-26
Abstract: A method for shredding, blending, and packaging wastes so that the shipment of waste is acceptable for transportation and disposal. Containerized wastes, laden with fissile isotopes, such as that from sodium fluoride traps and granulated carbon collection assemblies, if not already conditioned, are conditioned for blending by shredding them to particle size and then blending the particles with a grout mix either in a reusable mixing vessel or in a disposable mixing vessel. The blend of waste and grout is selected to meet governmental and disposal site requirements for an acceptable waste shipment. If blended in a reusable vessel, the blended waste is transferred to shipping containers. The shipping containers are placed in shielded shipping casks for transportation to a disposal facility. The grout mix is a combination of grout and neutron poisons such as borated sand to prevent criticality.
Patent CA-2684470-A1 (CA)
Title: Pyrimidine derivatives
Inventor: CUI YUMIN
IPC: A01N43/54
Filed: 2008-04-15
Abstract: Disclosed are pyrimidine compounds of formula (I) shown in the specification. Also disclosed is a method of treating an angiogenesis-related disorder, e.g., cancer or age-related macular degeneration, with such a compound.
Patent CA-2686898-A1 (CA)
Title: Method and apparatus for forming a turbofan mixer
Inventor: GEKHT EUGENE
IPC: F02K1/48
Filed: 2009-12-02
Abstract: The method for forming a turbofan mixer comprises providing a single monolithic and generally flat annular sheet metal blank, providing a die surface substantially corresponding in shape to a turbofan mixer shape, positioning the blank with reference to the die surface, and forcing the blank against the die surface to transform the blank into a monolithic turbofan mixer.
Patent CA-2687380-A1 (CA)
Inventor: TALEUX NELLIE
IPC: A61P3/10
Filed: 2008-05-16
Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, at least one hormone chosen among 3,5-diiodothyronine (3,5-T2), 3',3- diiodothyronine (3',3-T2), 3',5-diiodothyronine (3 ',5-T2), 3 '-iodothyronine (3'-T), 3- iodothyronine (3-T) or 5 -iodothyronine (5-T), in association with a pharmaceutically acceptable vehicle.
Patent CA-2688841-A1 (CA)
Inventor: KORDA DANIEL
IPC: B65D1/34
Filed: 2009-12-04
Abstract: The present invention relates to drain pans and the process of making the same, and more particularly to a leak proof drain pan that is semi-stackable during storage and can be manufactured from a single piece of steel without the use of a press, die or tooling. The drain pan includes corner sections created from a unique folding system which eliminates seams and thus the need for any sealing of the seams.
Patent CA-2691464-A1 (CA)
Inventor: AMCOFF HENRIK
IPC: B64F5/00
Filed: 2010-02-01
Abstract: A spray cleaning device for cleaning an auxiliary power unit (APU) within an aircraft comprises one or more spray nozzles, a water tube for supplying water to the nozzles, and positioning means. A system for cleaning APUs comprises a spray cleaning device and a supply system for providing pressurized and temperature controlled washing fluid to the cleaning device. A method for cleaning APUs comprises providing a spray cleaning device, attaching the cleaning device to an air inlet structure of an aircraft, and supplying washing fluid to the cleaning device at a desired spray pressure, spray temperature, and spray droplet size.
Patent CA-2695533-A1 (CA)
Title: Methods, systems, and computer program products for locating and tracking objects
Inventor: TROXLER ROBERT ERNEST
IPC: H04W4/80
Filed: 2008-06-09
Abstract: Methods, systems, and computer program products for locating and tracking objects are disclosed. According to one system, a locating device can be configured to determine a location of an object. According to another system, an identifying device can be configured to determine the identification of an object. Further, a tracking system configured to store tracking information associated with the object. A communications system can be configured to communicate a signal to a remote computer device that identifies the location of the object and includes the tracking information associated with the object.
Patent CA-2696016-A1 (CA)
Inventor: BOLEA CHRISTELLE
IPC: A61K31/4439
Filed: 2008-07-10
Abstract: The present invention relates to novel compounds of Formula (I), wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, M1, M2, M3, A m, B n are defined in Formula (I), invention compounds are modulators of metabotropic glutamate receptors - subtype 4 ("mGluR4") which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.
Patent CA-2698038-A1 (CA)
Title: Systems and methods for delivering drugs
Inventor: CHIANG YET-MING
IPC: A61M5/148
Filed: 2008-07-28
Abstract: A patch pump device generally includes at least one fluid source (604), a fluid communicator, and an electrochemical actuator (602). The fluid communicator is in fluid communication with the fluid source. The electrochemical actuator is operative to cause fluid to be delivered from the fluid source into the fluid communicator. Preferably, the electrochemical actuator comprises a charged electrochemical cell, and at least a portion of the electrochemical cell changes its volume or position in response to an applied current or voltage to cause the fluid to be delivered.
Patent CA-2698512-A1 (CA)
Inventor: SPOERER ROLAND
IPC: C11D1/52
Filed: 2008-09-06
Abstract: Concentrated fatty alcohol sulfate preparations which comprise more than 35% by weight of fatty alcohol sulfate (FAS) are described. The compositions are aqueous, but, besides the FAS, also comprise polyols or oil-soluble betaines. They are suitable for the production of detergents and cleaners, but also for the production of cosmetic compositions, in particular of dental care compositions.
Patent CA-2699631-A1 (CA)
Title: Pyridazinone compounds and p2x7 receptor inhibitors
Inventor: SHIGETA YUKIHIRO
IPC: C07D401/06
Filed: 2008-10-30
Abstract: Novel pyridazinone compounds of formula (I), which inhibit the purinergic P2X7 receptor and are useful for prevention, therapy and improvement of inflammatory and immunological diseases.
Patent CA-2702404-A1 (CA)
Inventor: NELSON KEITH R
IPC: E21B23/00
Filed: 2010-04-29
Abstract: A downhole tractor assembly that is configured for open-hole applications. The assembly includes a force monitoring mechanism to help monitor and control forces imparted through a drive mechanism of the tractor in real time. As such, damage to open-hole formations due to excessive tractoring forces may be minimized along with mechanical damage to the tractor. Furthermore, the drive mechanism of the tractor may include multiple sondes and bowsprings with gripping saddles specially configured for contacting the well wall across a large area in a non-point and line manner so as to avoid digging into and damaging the well wall during tractoring.
Patent CA-2704443-A1 (CA)
Inventor: PINKSTONE FELICIA A
IPC: B65D5/42
Filed: 2010-05-14
Abstract: A carton including a back panel and a bottom panel is provided. The back panel is foldably connected along a first fold line to a first accordion panel and a second accordion panel is foldably connected along a second fold line to the first accordion panel.  The back panel, the first accordion panel, and the second accordion panel are movable between a first position and a second position. In the first position, the first accordion panel and the second accordion panel are substantially parallel to the back panel and are substantially perpendicular to the bottom panel. In the second position, the back panel moves toward the bottom panel, the second accordion panel is substantially parallel the bottom panel, and the first accordion panel is disposed diagonally between the second fold line and the back panel. Articles in the carton thus can be slanted toward the back panel in the second position.
Patent CA-2705402-A1 (CA)
Inventor: SPRENGERS WOLFGANG
IPC: A61B5/00
Filed: 2008-11-12
Abstract: The invention concerns an analyzer (1), preferably for analysing body fluids, which has one or several exchangeable cassettes (2, 3, 4, 5) (consumables) that contain operating liquids, operating materials and/or consumables and can be inserted into corresponding holders (17) of the analyzer (1), wherein the analyzer (1) has a system (6) for exchanging ambient air which has a filter unit (7) on the inlet side of the analyzer (1) to filter the ambient air that needs to be exchanged. The filter unit (7) is integrated into at least one of the exchangeable cassettes (2, 3, 4, 5) in order to minimize amount of maintenance for the analyzer (1).
Patent CA-2706372-A1 (CA)
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: A61K31/517
Filed: 2008-07-10
Abstract: Crystalline Form (IV) of doxazosin mesylate, a process for its preparation and uses thereof.
Patent CA-2707444-A1 (CA)
Title: Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
Inventor: MOHAPATRA SHYAM S
IPC: A61K31/7088
Filed: 2008-11-26
Abstract: Methods, compositions and devices are provided by the present invention for reducing activity of a natriuretic peptide receptor and other signals. Therapeutic treatments are provided by use of polynucleotides encoding a natriuretic peptide or by regulating the expression of natriuretic peptide receptor, such as NPRA and NPRC, or combinations of these therapies. Routes used for delivering polynucleotides encoding a natriuretic peptide, or, for example, siRNA that down regulates natriuretic peptide receptor include subcutaneous injection, oral gavage, transdermal and intranasal delivery routes. Compositions can include chitosan.  chitosan derivatives, and chitosan derivative and a lipid. Transdermal delivery can use a transdermal cream. Intranasal delivery can use a dropper or an aspirator for delivery of a mist. Oral gavage delivers equivalent to oral delivery. Delivery permits cell and tissue specific targeting of gene therapies resulting in expression of a natriuretic peptide or down regulation of natriuretic peptide receptor.  A variety of cancers, asthma and viral diseases can be treated therapeutically using the methods and compositions of the present invention.
Patent CA-2707532-A1 (CA)
Inventor: HAMMERL ALOIS
IPC: B65D75/32
Filed: 2007-12-04
Abstract: The present invention relates to a packaging arrangement (1) for bottles (12) of small volume, having a first packaging element (2) and a second packaging element (3), wherein each of the first and the second packaging elements (2, 3) has at least two depressions (4, 4') spaced apart from each other and formed in in a dimensionably stable manner, whose openings are surrounded by strips (10, 10') with substantially level surfaces, by means of which the packaging elements (2, 3) are connected with each other in a manner sealed against fluids and releasably. The depressions (4, 4') are equipped with spacing ribs (5, 5'), which are distributed over the circumference, which fix the bottles and the closures in place.     (Fig. 1).
Patent CA-2708466-A1 (CA)
Title: Mount with separate device interface
Inventor: LUNDRIGAN SHANNON
IPC: A47B21/04
Filed: 2010-06-29
Abstract: The present invention relates to mounting devices, and in particular to a mount for mounting a device or other object on a suitable support structure such as a slatwall. In one embodiment, the mount comprises a support structure interface engageable with a support structure, the support structure interface comprising a base having a first side and a second side opposite the first side, and at least one engagement member extending from the first side for engaging the support structure, and a mounting slot at the second side of the base. The mount further comprises a separate device interface comprising at least one male portion receivable into the mounting slot of the support structure interface and at least one connector portion connectable to a device that is to be mounted.
Patent CA-2709176-A1 (CA)
Inventor: SHAGINIAN ALEKSANDR
IPC: C07D487/04
Filed: 2008-12-12
Abstract: Described herein are novel enzyme inhibitors. In some embodiments, the enzyme inhibitors are reverse transcriptase inhibitors, particularly HIV reverse transcriptase inhibitors. Also described herein are compositions containing them and methods of using them. Thus, the compounds and compositions described herein are useful for the in vitro and in vivo inhibition of HIV reverse transcriptase as a method of treating or preventing HIV, AIDS  or related disorders.
Patent CA-2710301-A1 (CA)
Inventor: RINCENT MICHEL
IPC: H02M1/12
Filed: 2008-12-19
Abstract: The present invention relates to a power-factor correction circuit for a three-phase power supply. The correction circuit comprises a filtering unit at the input receiving the three phases of the current, at least one inductor per phase placed downstream of the filtering unit, a rectifying bridge powering a current-chopping stage, characterized in that the filtering unit comprises a differential-mode filtering cell comprising at least one inductive circuit (511) formed of a single magnetic material in a double E, each leg of the E being surrounded by a winding. The invention applies notably to the field of power electronics, in particular to the production of three-phase power supply units.
Patent CA-2711716-A1 (CA)
Title: Method and apparatus for selective data encryption
Inventor: MASSOUDI AYOUB
IPC: H04N7/167
Filed: 2009-01-16
Abstract: A layered audiovisual packet data stream (CNT'), such as one obtained by a JPEG2000 encoder (810), is received together with information (metadata) about the contribution of each packet to the reduction of image distortion. The distortion-to-rate ratio for each packet is calculated (710) and the packets are ordered (720) is descending ratio. The non-encrypted packet having the highest ratio is encrypted (730) until the target distortion is obtained. Also provided is an apparatus (800). In a variant, the data in the packets are substituted by dummy data instead of encrypted.
Patent CA-2712627-A1 (CA)
Inventor: RUBEN MANON S
IPC: G16H10/60
Filed: 2009-02-06
Abstract: A computer-implemented method for grouping, categorizing, and profiling pharmaceutical claims data to assist health care managers in determining (a) medication treatment experience, outcomes, and medication compliance behaviors of patients and (b) appropriate drug prescribing, medication coordination, and cost-efficiency of health care providers. An objective means is provided for categorizing and quantifying patterns of prescription drag utilization as a health care service within a clinically relevant time frame. A pharmacy episode group (PEG) is a pharmacologically homogenous grouping of drags with the same therapeutic ingredients used by a patient once or over an extended period of time. The PEG is a patient-centered pharmacy classification unit, which uses script-level pharmacy claim data as input data and assigns each script to the appropriate episode. Pharmacy episodes are categorized based on algorithms linking the pattern of a physician's recommended use (drag supply) and the patient's pattern of compliance (intervals between fill dates). The system also identifies multi-drag and concurrent use drag episodes, flags patients' records where intervals between scripts suggest non- compliance with recommended therapy, selects the most recent claims, resets windows (episode start and end dates), and ultimately assigns all pharmacy claims to episodes.
Patent CA-2713284-A1 (CA)
Title: Blade outer air seal cooling
Inventor: DI PAOLA FRANCO
IPC: F02C7/28
Filed: 2010-08-13
Abstract: A blade outer air seal (BOAS) segment has a plurality of cooling passages axially extending through a platform of the BOAS segment. The passages each have an inlet defined in a radially outer surface and an exit defined on a leading edge of the platform. At least one of the passages positioned close to respective circumferential sides of the platform extends linearly from one of the inlets and is skewed away from the axial direction to cool a corner area of the platform.
Patent CA-2716077-A1 (CA)
Inventor: STRETCH MITCHEL
IPC: E21B47/06
Filed: 2010-09-28
Abstract: A coiled tubing assembly includes coiled tubing having a side wall that defines an opening and an insert covering the opening and affixed to the coiled tubing.  The coiled tubing has a longitudinal axis. The insert defines a capillary window therethrough. The opening and the insert include ends that are non-perpendicular to the longitudinal axis.  A method of making a coiled tubing assembly includes providing coiled tubing defining a side wall opening and pulling a capillary tube into the interior of the coiled tubing through the side wall opening. The method further includes attaching the capillary tube to a capillary window of an insert for covering the side wall opening and affixing the insert to the coiled tubing.
Patent CA-2724605-A1 (CA)
Inventor: OLD DAVID W
IPC: A61K31/5375
Filed: 2009-05-13
Abstract: Therapeutic compounds, methods, and compositions are disclosed herein for treating glaucoma and baldness in mammals. The specific compounds are described herein and are modified prostaglandin derivates.
Patent CA-2724903-A1 (CA)
Inventor: JOANNY FABIENNE
IPC: A61K9/70
Filed: 2009-05-20
Abstract: The present invention relates to use of a matrix for the oral administration, in tablet form, of gradual continuous release Mg provided with a protective coating slowing down the gastric dissolution of the Mg, said matrix being characterized in that it includes, for the administration (A) of 90 to 110 parts by weight of magnesium, the following ingredients: (B1) 180 to 190 parts by weight of hydroxypropylmethyl cellulose; (B2) 19.8 to 22.2 parts by weight of glyceryl behenate; (C1) 10 to 12 parts by weight of lactose; and (C2) 10 to 12 parts by weight of colloidal silica. The invention also relates to the gradual release composition including said matrix and the coating thereof.
Patent CA-2726156-A1 (CA)
Title: Apparatus and assembly for a spark igniter
Inventor: MEE BRENDON FRANCIS
IPC: F23Q3/00
Filed: 2010-12-22
Abstract: An apparatus and assembly for an igniter is provided. The igniter includes a shell comprising a base, a tip surface, and a sidewall extending therebetween wherein the sidewall surrounds a cavity within the shell. The igniter also includes a shell bore extending from the tip surface to the cavity and a pin embedded into the tip surface extending substantially tangentially with respect to the bore.
Patent CA-2728943-A1 (CA)
Inventor: DIEBOLD STEFFEN
IPC: D06F58/20
Filed: 2011-01-19
Abstract: A hinge pulley for a household appliance having a housing, a washing container in the housing, a door pivotable about a horizontal axis at the lower part of the door between an open and a closed position for accessing an interior of the washing container, and a transmission element coupled between the door and the housing. The hinge pulley includes a unitary molded body having an integral first channel having a first curved portion for guiding the transmission element, and an integral second channel having a second curved portion for guiding the transmission element, wherein a portion of one of the integral first channel and the integral second channel includes a sliding surface formed from an ultra high molecular weight material.
Patent CA-2729839-A1 (CA)
Inventor: RETALLACK DIANE
IPC: C12N15/78
Filed: 2009-07-01
Abstract: Methods of identifying and expressing an antibody variant are disclosed wherein the method comprises identifying a binding region in an antibody, fusing the binding region to a plurality of scaffolds of antibody constant regions to obtain antibody fragment variants, expressing the antibody fragment variants in organisms to form constructs and expressing the constructs carried by the organisms to form induced cultures, wherein the organisms are expressed in HTP mode.